133 related articles for article (PubMed ID: 11407950)
21. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
[TBL] [Abstract][Full Text] [Related]
22. Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines.
Melnikova VO; Bolshakov SV; Walker C; Ananthaswamy HN
Oncogene; 2004 Mar; 23(13):2347-56. PubMed ID: 14743208
[TBL] [Abstract][Full Text] [Related]
23. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
24. Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.
Recio JA; Noonan FP; Takayama H; Anver MR; Duray P; Rush WL; Lindner G; De Fabo EC; DePinho RA; Merlino G
Cancer Res; 2002 Nov; 62(22):6724-30. PubMed ID: 12438273
[TBL] [Abstract][Full Text] [Related]
25. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
Leong WF; Chau JF; Li B
Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
[TBL] [Abstract][Full Text] [Related]
26. Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma.
O'Hagan RC; Brennan CW; Strahs A; Zhang X; Kannan K; Donovan M; Cauwels C; Sharpless NE; Wong WH; Chin L
Cancer Res; 2003 Sep; 63(17):5352-6. PubMed ID: 14500367
[TBL] [Abstract][Full Text] [Related]
27. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
28. [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis].
Soufir N; Basset-Seguin N
Bull Cancer; 2001 Nov; 88(11):1061-7. PubMed ID: 11741799
[TBL] [Abstract][Full Text] [Related]
29. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
[TBL] [Abstract][Full Text] [Related]
30. Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.
King D; Yang G; Thompson MA; Hiebert SW
Oncogene; 2002 Jul; 21(32):4978-82. PubMed ID: 12118376
[TBL] [Abstract][Full Text] [Related]
31. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
[TBL] [Abstract][Full Text] [Related]
32. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.
Ackermann J; Frutschi M; Kaloulis K; McKee T; Trumpp A; Beermann F
Cancer Res; 2005 May; 65(10):4005-11. PubMed ID: 15899789
[TBL] [Abstract][Full Text] [Related]
33. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
[TBL] [Abstract][Full Text] [Related]
34. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3931-6. PubMed ID: 17360455
[TBL] [Abstract][Full Text] [Related]
35. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF.
Rizos H; Puig S; Badenas C; Malvehy J; Darmanian AP; Jiménez L; Milà M; Kefford RF
Oncogene; 2001 Sep; 20(39):5543-7. PubMed ID: 11571653
[TBL] [Abstract][Full Text] [Related]
36. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
Bardeesy N; Aguirre AJ; Chu GC; Cheng KH; Lopez LV; Hezel AF; Feng B; Brennan C; Weissleder R; Mahmood U; Hanahan D; Redston MS; Chin L; Depinho RA
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5947-52. PubMed ID: 16585505
[TBL] [Abstract][Full Text] [Related]
37. Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.
Ming Z; Lim SY; Rizos H
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33076392
[TBL] [Abstract][Full Text] [Related]
38. p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis.
González-Navarro H; Abu Nabah YN; Vinué A; Andrés-Manzano MJ; Collado M; Serrano M; Andrés V
J Am Coll Cardiol; 2010 May; 55(20):2258-68. PubMed ID: 20381282
[TBL] [Abstract][Full Text] [Related]
39. Somatic p16(INK4a) loss accelerates melanomagenesis.
Monahan KB; Rozenberg GI; Krishnamurthy J; Johnson SM; Liu W; Bradford MK; Horner J; Depinho RA; Sharpless NE
Oncogene; 2010 Oct; 29(43):5809-17. PubMed ID: 20697345
[TBL] [Abstract][Full Text] [Related]
40. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.
Debies MT; Gestl SA; Mathers JL; Mikse OR; Leonard TL; Moody SE; Chodosh LA; Cardiff RD; Gunther EJ
J Clin Invest; 2008 Jan; 118(1):51-63. PubMed ID: 18060046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
